Skip to main content

Table 1 Demographics and pre- and postoperative findings of the patients

From: Investigating the clinical outcomes of bulking agent injection in comparison with modified Gil-Vernet anti-vesicoureteral reflux surgery in children with high-grade reflux (4 or 5)

 

Total

modified Gil-Vernet group

Dx/HA group

P-value

Sex

 Female

123

82

41

N/S

 Male

56

46

10

 

Age (mean ± SD)

3.69 ± 1.0

3.7 ± 1.1

3.6 ± 0.9

N/S

Grading

 4

120

87

33

N/S

 5

59

41

18

 

Duration of surgery (min, mean ± SD)

49 ± 12

57 ± 11

21 ± 8

0.01

Duration of hospitalization (days, mean ± SD)

2.94 ± 1.30

3.50 ± 0.50

0.34 ± 0.22

 < 0.001

Complications

 Dysuria

89 (50%)

73 (57%)

16 (31%)

0.011

 Fever

10 (6%)

8 (6%)

2 (4%)

N/S

 Pyuria

43 (24%)

32 (24.8%)

11 (21.4%)

N/S

 Hematuria

68 (38%)

57 (45%)

8 (14%)

0.014

 U/C

34 (19%)

26 (20%)

8 (14%)

N/S

 Febrile UTI

11 (6%)

8 (6%)

3 (5%)

N/S

 Flank pain

16 (8%)

10 (7%)

6 (11%)

N/S

  1. N/S; not significant, Dx/HA; dextranomer/hyaluronic acid, U/C; urine culture, UTI; urinary tract infection